Abstract |
This study describes antipsychotic use and metabolic monitoring rates among individuals with developmental disabilities enrolled in a subspecialty medical home (N = 826). Four hundred ninety-nine participants (60.4 %) were taking antipsychotics, which was associated with male gender (p = 0.01), intellectual disability with and without autism spectrum disorder (p = 0.001 and p = 0.04, respectively), and inversely associated with the youngest and oldest age categories (p = 0.001 and p = 0.04, respectively). Among those taking antipsychotics, annual metabolic monitoring rates ranged from 89 % ( lipids) to 99 % (weight). Age was positively associated with glucose (p < 0.001) and lipid monitoring (p < 0.001). Adult participants with dyslipidemia (p < 0.01), prediabetes/diabetes (p = 0.04), and hypertension (p = 0.02) were significantly more likely to obtain lipid monitoring. These values exceeded previously reported rates suggesting the importance of an integrated care model.
|
Authors | Lisa M Ruiz, Mackenzie Damron, Kyle B Jones, Dean Weedon, Paul S Carbone, Amanda V Bakian, Deborah A Bilder |
Journal | Journal of autism and developmental disorders
(J Autism Dev Disord)
Vol. 46
Issue 6
Pg. 1887-1894
(06 2016)
ISSN: 1573-3432 [Electronic] United States |
PMID | 26818535
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antipsychotic Agents
- Lipids
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antipsychotic Agents
(pharmacology, therapeutic use)
- Autism Spectrum Disorder
(complications, drug therapy, metabolism)
- Body Weight
(drug effects)
- Child
- Child, Preschool
- Developmental Disabilities
(complications, drug therapy, metabolism)
- Female
- Humans
- Intellectual Disability
(complications, drug therapy, metabolism)
- Lipids
(blood)
- Male
- Medicaid
- Middle Aged
- Patient-Centered Care
- Sex Factors
- United States
- Young Adult
|